MIND NRG SA has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV LEIDEN MEDICAL CT, DE STAAT DER NEDERLANDEN VERT DOOR DE MINISTER VAN VWS and THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Schrattenholz Andre | 10 |
#2 | Baussant Thierry | 8 |
#3 | Bach Daniel | 8 |
#4 | Schrattenholz André | 2 |
#5 | Thierry Baussant | 1 |
#6 | Andre Schrattenholz | 1 |
#7 | Daniel Bach | 1 |
Publication | Filing date | Title |
---|---|---|
KR20130113962A | Neuregulin isoforms, neuregulin polypeptides and uses thereof |